Submitted:
17 August 2022
Posted:
23 August 2022
You are already at the latest version
Preprints on COVID-19 and SARS-CoV-2
Abstract
This proposal was prepared in the very first weeks of 2020 because of the outbreak of COVID-19.There is good reason to suppose that rotavirus vaccine can be used as protection tool to effectively and safely fight and mitigate SARS-CoV-2 infection and the impact caused by COVID-19 in adult humans, due to the development of cross and trained immunity following rotavirus vaccination. Up-to-date, some rotavirus vaccines are available and approved, two of them have a large experience in results and safety. Little experience has been achieved in the use of rotavirus vaccine in adults. However, it can be expected that it would be safe and effective in adults and in the elderly as well. This proposal explains the background.
Keywords:
rotavirus
; coronavirus
; vaccine
; SARS-CoV-2
; COVID-19
; cross immunity
; trained immunity
; vaccinated breakthrough infections
; COVID variants
; long-Covid
; post-viral syndrome
; chronic fatigue
; booster
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
